PRMT5 and neoplasm: The genetic ablation of PRMT5 resulted in remarkably reduced cell proliferation of Granta-519 (Supplementary Fig. S4e, f), consistent with the tumor proliferation suppressive effect of PRMT5 inhibitors (Supplementary Fig. S1c, d).